Amphetamine‐stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates
暂无分享,去创建一个
Marc Laruelle | Eileen O. Smith | R. Roth | E. Sybirska | J. Seibyl | D. Charney | M. Laruelle | G. Heninger | S. Zoghbi | R. Innis | R. Baldwin | R. Malison | P. Hoffer | J. Elsworth | Robert B. Innis | Robert T. Malison | Mohammed Al‐Tikriti | Paul B. Hoffer | Elzbieta H. Sybirska | John P. Seibyl | Sami S. Zoghbi | Ronald M. Baldwin | Eileen O. Smith | Dennis S. Charney | George Heninger | John D. Elsworth | Robert H. Roth | M. Al-Tikriti
[1] B. Brodie,et al. EVIDENCE FOR RELEASE OF BRAIN AMINES BY RESERPINE IN PRESENCE OF MONOAMINE OXIDASE INHIBITORS: IMPLICATION OF MONOAMINE OXIDASE IN NOREPINEPHRINE METABOLISM IN BRAIN , 1960 .
[2] C. Goetz,et al. Tardive dyskinesia: review and update. , 1980, The American journal of psychiatry.
[3] J. Mazziotta,et al. Study of Cerebral Function with Positron Computed Tomography , 1982, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[4] J. Coyle,et al. Dopaminergic dysfunction in tourette syndrome , 1982 .
[5] B. McMillen. CNS stimulants: two distinct mechanisms of action for amphetamine-like drugs , 1983 .
[6] G. Pearlson,et al. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. , 1986, Science.
[7] P Riederer,et al. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases. , 1987, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[8] R. Roth,et al. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF , 1987, Brain Research.
[9] F. Bloom,et al. Cellular and molecular mechanisms of drug dependence. , 1988, Science.
[10] J A Parker,et al. Quantitative SPECT: basic theoretical considerations. , 1989, Seminars in nuclear medicine.
[11] J. Langston. Current theories on the cause of Parkinson's disease. , 1989, Journal of neurology, neurosurgery, and psychiatry.
[12] P. Seeman,et al. Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: Implications for positron emission tomography of the human brain , 1989, Synapse.
[13] R. Roth,et al. Cocaine increases extracellular dopamine in rat nucleus accumbens and ventral tegmental area as shown by in vivo microdialysis , 1989, Neuroscience Letters.
[14] D. Segal,et al. Reserpine enhances amphetamine stereotypies without increasing amphetamine-induced changes in striatal dialysate dopamine , 1989, Brain Research.
[15] H. Kung,et al. Peracetic acid as a superior oxidant for preparation of [123I]IBZM: A potential dopamine D‐2 receptor imaging agent , 1989 .
[16] R. Roth,et al. Symptomatic and asymptomatic 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridinetreated primates: Biochemical changes in striatal regions , 1989, Neuroscience.
[17] P S Goldman-Rakic,et al. Dopamine D2 receptors in the cerebral cortex: distribution and pharmacological characterization with [3H]raclopride. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[18] A. Alavi,et al. In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] L. W. Thompson. The dopamine hypothesis of schizophrenia. , 2009, Perspectives in psychiatric care.
[20] S. Stone-Elander,et al. D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride. , 1990, Archives of general psychiatry.
[21] N. Hiroi,et al. The reserpine-sensitive dopamine pool mediates (+)-amphetamine-conditioned reward in the place preference paradigm , 1990, Brain Research.
[22] A. Alavi,et al. In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[23] J S Fowler,et al. Amphetamine induced decreases in (18F)‐N‐methylspiroperidol binding in the baboon brain using positron emission tomography (PET) , 1991, Synapse.
[24] Svante B. Ross,et al. Synaptic Concentration of Dopamine in the Mouse Striatum in Relationship to the Kinetic Properties of the Dopamine Receptors and Uptake Mechanism , 1991, Journal of neurochemistry.